SLC5A9
gene geneOn this page
Also known as SGLT4
Summary
SLC5A9 (solute carrier family 5 member 9, HGNC:22146) is a protein-coding gene on chromosome 1p33, encoding Sodium/glucose cotransporter 4 (Q2M3M2). Electrogenic Na(+)-coupled sugar symporter that may play a primary role in D-mannose and possibly D-fructose and D-glucose transport at the plasma membrane.
Predicted to enable D-glucose:sodium symporter activity. Predicted to be involved in hexose transmembrane transport. Located in extracellular exosome.
Source: NCBI Gene 200010 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 150 total
- MANE Select transcript:
NM_001011547
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22146 |
| Approved symbol | SLC5A9 |
| Name | solute carrier family 5 member 9 |
| Location | 1p33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SGLT4 |
| Ensembl gene | ENSG00000117834 |
| Ensembl biotype | protein_coding |
| OMIM | 620216 |
| Entrez | 200010 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000236495, ENST00000425816, ENST00000438567, ENST00000441260, ENST00000471020, ENST00000493837, ENST00000525901, ENST00000527929, ENST00000532322, ENST00000533824, ENST00000906153, ENST00000906154
RefSeq mRNA: 2 — MANE Select: NM_001011547
NM_001011547, NM_001135181
CCDS: CCDS30709, CCDS44136
Canonical transcript exons
ENST00000438567 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000771858 | 48228850 | 48228954 |
| ENSE00000771859 | 48229295 | 48229459 |
| ENSE00000771862 | 48231946 | 48232151 |
| ENSE00001925970 | 48247335 | 48248638 |
| ENSE00003514780 | 48235729 | 48235879 |
| ENSE00003545034 | 48233655 | 48233762 |
| ENSE00003589175 | 48231545 | 48231625 |
| ENSE00003603520 | 48237679 | 48237847 |
| ENSE00003625040 | 48224724 | 48224795 |
| ENSE00003638422 | 48232367 | 48232502 |
| ENSE00003668643 | 48230600 | 48230705 |
| ENSE00003671769 | 48239322 | 48239537 |
| ENSE00003679777 | 48242457 | 48242616 |
| ENSE00003903693 | 48222716 | 48222898 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 96.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4096 / max 191.2281, expressed in 49 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2788 | 0.3825 | 44 |
| 2789 | 0.0271 | 15 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 96.89 | gold quality |
| jejunal mucosa | UBERON:0000399 | 94.27 | gold quality |
| duodenum | UBERON:0002114 | 91.29 | gold quality |
| kidney epithelium | UBERON:0004819 | 90.42 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 89.09 | gold quality |
| small intestine | UBERON:0002108 | 88.28 | gold quality |
| sperm | CL:0000019 | 83.49 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.01 | gold quality |
| right lung | UBERON:0002167 | 81.79 | gold quality |
| right lobe of liver | UBERON:0001114 | 81.53 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.06 | silver quality |
| sural nerve | UBERON:0015488 | 79.95 | gold quality |
| tibial nerve | UBERON:0001323 | 78.41 | gold quality |
| mucosa of stomach | UBERON:0001199 | 78.12 | gold quality |
| body of pancreas | UBERON:0001150 | 77.84 | gold quality |
| liver | UBERON:0002107 | 77.51 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 77.12 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.46 | gold quality |
| endocervix | UBERON:0000458 | 76.27 | gold quality |
| kidney | UBERON:0002113 | 76.13 | gold quality |
| cortex of kidney | UBERON:0001225 | 75.77 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 75.55 | gold quality |
| jejunum | UBERON:0002115 | 75.48 | gold quality |
| upper arm skin | UBERON:0004263 | 75.30 | gold quality |
| upper lobe of lung | UBERON:0008948 | 75.27 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.25 | silver quality |
| apex of heart | UBERON:0002098 | 74.56 | gold quality |
| left ovary | UBERON:0002119 | 74.56 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 74.52 | gold quality |
| right ovary | UBERON:0002118 | 74.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
70 targeting SLC5A9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
Literature-anchored findings (GeneRIF, showing 1)
- SGLT4 would have unique physiological functions (i.e., absorption and/or reabsorption of Man, 1,5AG, and Fru, in addition to Glc). (PMID:15607332)
Cross-species orthologs
15 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc5a9 | ENSDARG00000005518 |
| mus_musculus | Slc5a9 | ENSMUSG00000028544 |
| rattus_norvegicus | Slc5a9 | ENSRNOG00000042950 |
| drosophila_melanogaster | CG2187 | FBGN0017448 |
| drosophila_melanogaster | rumpel | FBGN0029950 |
| drosophila_melanogaster | SLC5A11 | FBGN0031998 |
| drosophila_melanogaster | bumpel | FBGN0037895 |
| drosophila_melanogaster | ChT | FBGN0038641 |
| drosophila_melanogaster | salt | FBGN0039872 |
| drosophila_melanogaster | Smvt | FBGN0039873 |
| drosophila_melanogaster | CG31262 | FBGN0051262 |
| drosophila_melanogaster | CG31668 | FBGN0051668 |
| drosophila_melanogaster | CG33124 | FBGN0053124 |
| drosophila_melanogaster | kumpel | FBGN0250757 |
| caenorhabditis_elegans | WBGENE00000501 |
Paralogs (12): SLC5A1 (ENSG00000100170), SLC5A4 (ENSG00000100191), SLC5A5 (ENSG00000105641), SLC5A7 (ENSG00000115665), SLC5A6 (ENSG00000138074), SLC5A2 (ENSG00000140675), SLC5A12 (ENSG00000148942), SLC5A10 (ENSG00000154025), SLC5A11 (ENSG00000158865), SLC5A3 (ENSG00000198743), SLC5A8 (ENSG00000256870), (ENSG00000293606)
Protein
Protein identifiers
Sodium/glucose cotransporter 4 — Q2M3M2 (reviewed: Q2M3M2)
Alternative names: Solute carrier family 5 member 9
All UniProt accessions (4): Q2M3M2, F8WD86, H0Y5P9, H0YC92
UniProt curated annotations — full annotation on UniProt →
Function. Electrogenic Na(+)-coupled sugar symporter that may play a primary role in D-mannose and possibly D-fructose and D-glucose transport at the plasma membrane. Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump. Exclusively recognizes sugar substrates having a pyranose ring with an axial hydroxyl group on carbon 2.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in the small intestine, kidney and liver.
Similarity. Belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2M3M2-1 | 1 | yes |
| Q2M3M2-2 | 2 | |
| Q2M3M2-3 | 3 |
RefSeq proteins (2): NP_001011547, NP_001128653 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001734 | Na/solute_symporter | Family |
| IPR018212 | Na/solute_symporter_CS | Conserved_site |
| IPR038377 | Na/Glc_symporter_sf | Homologous_superfamily |
Pfam: PF00474
Catalyzed reactions (Rhea), 1 shown:
- D-mannose(out) + n Na(+)(out) = D-mannose(in) + n Na(+)(in) (RHEA:75475)
UniProt features (40 total): topological domain 14, transmembrane region 14, sequence variant 4, modified residue 2, splice variant 2, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2M3M2-F1 | 83.54 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 604, 605
Glycosylation sites (1): 251
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-189200 | Cellular hexose transport |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425407 | SLC-mediated transmembrane transport |
MSigDB gene sets: 93 (showing top):
GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GOBP_MONOATOMIC_CATION_TRANSPORT, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY, GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SYMPORTER_ACTIVITY
GO Biological Process (5): hexose transmembrane transport (GO:0008645), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)
GO Molecular Function (7): low-affinity D-glucose:sodium symporter activity (GO:0005362), D-glucose:sodium symporter activity (GO:0005412), carbohydrate:monoatomic cation symporter activity (GO:0005402), hexose transmembrane transporter activity (GO:0015149), symporter activity (GO:0015293), solute:sodium symporter activity (GO:0015370), transmembrane transporter activity (GO:0022857)
GO Cellular Component (3): plasma membrane (GO:0005886), extracellular exosome (GO:0070062), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| SLC-mediated transmembrane transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| solute:monoatomic cation symporter activity | 2 |
| monosaccharide transmembrane transport | 1 |
| metal ion transport | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| cellular process | 1 |
| D-glucose:sodium symporter activity | 1 |
| carbohydrate:monoatomic cation symporter activity | 1 |
| solute:sodium symporter activity | 1 |
| D-glucose transmembrane transporter activity | 1 |
| carbohydrate transmembrane transporter activity | 1 |
| hexose transmembrane transport | 1 |
| monosaccharide transmembrane transporter activity | 1 |
| secondary active transmembrane transporter activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| membrane | 1 |
| cell periphery | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
831 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC5A9 | SLC2A2 | P11168 | 554 |
| SLC5A9 | SLC2A5 | P22732 | 551 |
| SLC5A9 | GARIN5A | Q6IPT2 | 533 |
| SLC5A9 | SLC2A7 | Q6PXP3 | 507 |
| SLC5A9 | H7C1H1 | H7C1H1 | 501 |
| SLC5A9 | SLC2A11 | Q9BYW1 | 501 |
| SLC5A9 | WDR25 | Q64LD2 | 493 |
| SLC5A9 | SLC2A8 | Q9NY64 | 461 |
| SLC5A9 | TRABD2B | A6NFA1 | 460 |
| SLC5A9 | FAM8A1 | Q9UBU6 | 460 |
| SLC5A9 | SLC25A45 | Q8N413 | 452 |
| SLC5A9 | ANKRD50 | Q9ULJ7 | 451 |
| SLC5A9 | SLC16A13 | Q7RTY0 | 447 |
| SLC5A9 | TPRA1 | Q86W33 | 445 |
| SLC5A9 | PDHA2 | P29803 | 437 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EGFR | NDUFA4 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC5A9 | CD63 | psi-mi:“MI:0914”(association) | 0.530 |
| KLF8 | psi-mi:“MI:0914”(association) | 0.350 | |
| NTRK1 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| SLC5A9 | RER1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC6A1 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (32): CD63 (Affinity Capture-MS), GIF (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), LPHN1 (Affinity Capture-MS), ATP5E (Affinity Capture-MS), USMG5 (Affinity Capture-MS), ATP5I (Affinity Capture-MS), ATP5H (Affinity Capture-MS), ATP5J (Affinity Capture-MS), CD63 (Affinity Capture-MS), CERS1 (Affinity Capture-MS), CHPT1 (Affinity Capture-MS), FZD8 (Affinity Capture-MS)
ESM2 similar proteins: A0PJK1, A8I1B9, A8WHP3, B9NAE4, D3ZIS0, O02228, O77741, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P41251, P49279, P49280, P53790, P53791, P53792, P53793, P53794, P56436, P70553, P83740, Q27946, Q27981, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q7T384, Q8BGY9, Q8C3K6, Q8K0E3, Q8UWF0, Q8VDT1
Diamond homologs: A0PJK1, A8I1B9, A8WHP3, D3ZIS0, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P53790, P53791, P53792, P53793, P53794, P96169, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q8C3K6, Q8K0E3, Q8VDT1, Q8WWX8, Q91ZP4, Q923I7, Q9ET37, Q9JKZ2, Q9NY91, Q9Z1F2, P31448
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
150 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 112 |
| Likely benign | 14 |
| Benign | 16 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2094 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:48222897:GG:G | donor_gain | 1.0000 |
| 1:48222897:GGGT:G | donor_loss | 1.0000 |
| 1:48222898:GG:G | donor_gain | 1.0000 |
| 1:48222898:GGTA:G | donor_loss | 1.0000 |
| 1:48222899:G:GG | donor_gain | 1.0000 |
| 1:48222900:T:G | donor_loss | 1.0000 |
| 1:48224796:G:GG | donor_gain | 1.0000 |
| 1:48227893:G:GT | donor_gain | 1.0000 |
| 1:48227912:GACAT:G | donor_gain | 1.0000 |
| 1:48227913:ACATA:A | donor_gain | 1.0000 |
| 1:48228960:G:GT | donor_gain | 1.0000 |
| 1:48231539:CCCCA:C | acceptor_loss | 1.0000 |
| 1:48231540:CCCAG:C | acceptor_loss | 1.0000 |
| 1:48231541:CCAG:C | acceptor_loss | 1.0000 |
| 1:48231542:CA:C | acceptor_loss | 1.0000 |
| 1:48231543:A:T | acceptor_loss | 1.0000 |
| 1:48231624:GG:G | donor_gain | 1.0000 |
| 1:48231625:GG:G | donor_gain | 1.0000 |
| 1:48231625:GGTA:G | donor_loss | 1.0000 |
| 1:48231626:G:GA | donor_loss | 1.0000 |
| 1:48231627:T:A | donor_loss | 1.0000 |
| 1:48231631:G:GT | donor_gain | 1.0000 |
| 1:48232501:AGG:A | donor_loss | 1.0000 |
| 1:48232503:G:GA | donor_loss | 1.0000 |
| 1:48232503:G:GG | donor_gain | 1.0000 |
| 1:48232504:T:A | donor_loss | 1.0000 |
| 1:48233653:A:AG | acceptor_gain | 1.0000 |
| 1:48233654:G:GG | acceptor_gain | 1.0000 |
| 1:48233654:GAC:G | acceptor_gain | 1.0000 |
| 1:48233654:GACGA:G | acceptor_gain | 1.0000 |
AlphaMissense
4409 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:48237707:A:C | S441R | 0.999 |
| 1:48237709:C:A | S441R | 0.999 |
| 1:48237709:C:G | S441R | 0.999 |
| 1:48232484:A:C | S339R | 0.998 |
| 1:48232486:C:A | S339R | 0.998 |
| 1:48232486:C:G | S339R | 0.998 |
| 1:48235773:A:C | S396R | 0.998 |
| 1:48235775:C:A | S396R | 0.998 |
| 1:48235775:C:G | S396R | 0.998 |
| 1:48235797:A:C | S404R | 0.997 |
| 1:48235799:C:A | S404R | 0.997 |
| 1:48235799:C:G | S404R | 0.997 |
| 1:48228871:A:C | S86R | 0.996 |
| 1:48228873:C:A | S86R | 0.996 |
| 1:48228873:C:G | S86R | 0.996 |
| 1:48228883:A:C | S90R | 0.996 |
| 1:48228885:T:A | S90R | 0.996 |
| 1:48228885:T:G | S90R | 0.996 |
| 1:48228913:G:T | G100W | 0.996 |
| 1:48228943:T:C | F110L | 0.996 |
| 1:48228945:C:A | F110L | 0.996 |
| 1:48228945:C:G | F110L | 0.996 |
| 1:48235800:A:C | S405R | 0.996 |
| 1:48235802:C:A | S405R | 0.996 |
| 1:48235802:C:G | S405R | 0.996 |
| 1:48228863:T:C | L83P | 0.995 |
| 1:48233729:T:G | Y370D | 0.995 |
| 1:48237716:T:A | W444R | 0.995 |
| 1:48237716:T:C | W444R | 0.995 |
| 1:48237756:T:G | F457C | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000013850 (1:48240702 A>C,T), RS1000139813 (1:48241128 T>C), RS1000223891 (1:48225553 C>T), RS1000256565 (1:48247646 C>G), RS1000339502 (1:48228657 C>T), RS1000447909 (1:48241716 C>T), RS1000895124 (1:48228420 G>A), RS1000925011 (1:48242026 C>G,T), RS1000953142 (1:48235045 G>A), RS1001017774 (1:48242282 T>C,G), RS1001067054 (1:48246904 C>T), RS1001179617 (1:48222293 CTT>C), RS1001285800 (1:48228765 C>T), RS1001297296 (1:48248872 T>TACA), RS1001474249 (1:48246046 T>C)
Disease associations
OMIM: gene MIM:620216 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1151 | Metabolite levels | 9.000000e-08 |
| GCST009733_41 | Urinary metabolite levels in chronic kidney disease | 4.000000e-24 |
| GCST010219_3 | Attention deficit hyperactivity disorder (inattention symptoms) | 1.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010459 | aminoadipic acid measurement |
| EFO:0005116 | urinary metabolite measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Hexose transporter family
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | decreases expression, affects cotreatment | 4 |
| Cyclosporine | decreases expression | 4 |
| Aflatoxin B1 | decreases expression, decreases methylation, affects expression | 3 |
| bisphenol A | affects expression, affects cotreatment, decreases methylation | 2 |
| Acetaminophen | decreases expression | 2 |
| Benzo(a)pyrene | decreases expression, affects methylation | 2 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Ethanol | affects cotreatment, increases expression | 1 |
| Aldehydes | decreases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Endosulfan | affects cotreatment, decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Folic Acid | affects cotreatment, increases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Progesterone | affects cotreatment, increases expression | 1 |
| Quercetin | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4U7 | HuH7-SLC5A9-KO-c13 | Cancer cell line | Male |
| CVCL_D4U8 | HuH7-SLC5A9-KO-c7 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.